Posttransplant metabolic syndrome (PTMS)-obesity, hypertension, elevated triglycerides, low HDL and glucose intolerance-is a major contributor to morbidity after adult liver transplant. This analysis of the Withdrawal of Immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) pilot trial is the first prospective study of PTMS after pediatric liver transplant. Twenty children were en...

Posterior reversible encephalopathy syndrome is commonly associated with factors like hypertension, immunosuppression, uraemia, volume overload and electrolyte disturbances in post renal transplant patients. We report a case of (posterior reverssible encephalopathy syndrome) PRES in young post renal transplant patient where all these common associations were absent. High index of suspicion, cli...

Objectives: Cardiovascular diseases and risk factors are associated with adverse cardiac events following kidney transplant. Therefore, pre-transplant evaluation of cardiovascular is important for determining the risk. The objective this study to determine prevalence in transplant candidates. Methods: This a single-center observational which includes 174 end-stage renal disease patients (male: ...

Cardiovascular complications are a major cause of morbidity and the leading cause of mortality in renal transplant recipients. Multiple cardiovascular risk factors are often present before transplantation. Prior ischaemic heart disease, cerebrovascular disease and peripheral vascular disease predict post-transplantation mortality, as do older age, diabetes mellitus, smoking and length of time o...

T he development of pulmonary arterial hypertension in the setting of advanced liver disease (portopulmonary hypertension (POPH)) has certainly captured the attention of all liver transplant centres, but why? For patients with moderate-to-severe POPH (mean pulmonary artery pressure (mPAP) .35 mmHg and pulmonary vascular resistance (PVR) .400 dyne?s?cm-5), the risk of intra-operative death and p...

OBJECTIVES This study was designed to test the hypothesis that heterotopic heart transplant (HHT) patients have lower blood pressure than orthotopic cardiac transplant (OCT) patients because their native heart is involved in blood pressure homeostasis. BACKGROUND Hypertension occurs more frequently after OCT than after liver or lung transplantation, suggesting that transplantation of the heart ...

GOALS To define the influence of nonalcoholic fatty liver disease (NAFLD) and its associated comorbidities on liver transplant outcomes. BACKGROUND NAFLD cirrhosis is an increasing indication for transplant. The transplant outcomes of NAFLD patients with metabolic syndrome comorbidities remain unclear. STUDY We examined a single center, retrospective cohort between 2004 and 2007 to determin...

BACKGROUND Although the development of noncardiogenic pulmonary edema or pulmonary reimplantation response (PRR) after lung transplantation has been well described, the incidence has not been established and the relationship of PRR to clinical risk factors has not been analyzed. STUDY OBJECTIVES (1) To describe the incidence of PRR in lung transplant recipients, (2) to identify the predictors...

BACKGROUND Pulmonary hypertension (PH) is present in a significant proportion of patients with end stage renal disease (ESRD) and is of prognostic importance. Data on the effect of renal transplant on PH is very limited. In this study, the aim was to examine the effect of renal transplant on systolic pulmonary artery pressure (SPAP) determined by Doppler echocardiography. METHODS Analysis was...